Our activities are diversified across our business segments and markets and are aligned with our purpose to make high-quality medicines accessible to the people who need them.
Offer a broad product portfolio
We offer a broad and differentiated portfolio of more than 780 products. It includes high-quality generic and branded generic medicines and a growing number of in-licensed products.
Markets across geographies
We distribute our products in our markets through experienced sales and marketing teams. In the MENA region, around 2,000 representatives market our brands to doctors and pharmacists, while our sales teams in the US and Europe sell to a broad range of customers, including the leading wholesalers, pharmacy chains, governments and hospital purchasing organisations.
Develop and innovate
We are building a pipeline of products to meet the evolving needs of patients and healthcare professionals through investments in internal R&D, partnerships and strategic acquisitions.
Manufacture and maintain quality
Our extensive and high-quality manufacturing capabilities are at the heart of what we do. We have 31 plants across the Group that supply our global markets with a broad range of injectable and non-injectable products, including 12 US FDA-inspected plants and 12 EMA-inspected plants.
We provide patients across our markets with high-quality and affordable medicines.
By focusing on the engagement and development of our people, we provide long and rewarding careers for our talented and diverse workforce.
We have a long history of creating value for our shareholders.
Against Corruption Initiative
- Member of the United Nations Global
Compact and FTSE4Good
By acting responsibly and with integrity, we are benefiting the communities in which we operate.